Existing knowledge on Zn status biomarkers (1963–2021) with a particular focus on FADS1 and FADS2 diagnostic performance and recommendations for further research
Review (Published version)
Metadata
Show full item recordAbstract
The role of Zn in human health was discovered 60 years ago, and despite remarkable research efforts, a sufficiently sensitive and specific biomarker of Zn status is still lacking. Plasma/serum Zn, currently the best available and most accepted population Zn status indicator, responds well to severe Zn deficiency, yet, mild to moderate Zn deficiency states usually remain unrecognized. Identifying early-stage Zn deficiency requires additional robust markers of Zn status. This paper discusses the sensitivity, specificity, and responsiveness of plasma Zn concentrations to Zn interventions. It describes the biochemical and dietary basis for the causal association between Zn and fatty acid desaturases activity, FADS1 and FADS2, based on data collected through studies performed in animals and/or humans. The influence of potential confounders and covariates on the observed relationships is considered. Additional potential Zn biomarkers are discussed and suggestions for further research in this... area are provided.
Keywords:
Zn biomarkers / plasma/serum Zn / LA/DGLA / desaturases / thymulin / dietary Zn intakeSource:
Frontiers in Nutrition, 2023, 9, 1057156-Publisher:
- Frontiers Media S.A.
Funding / projects:
- Financial support for this study was provided by the HarvestPlus (www.HarvestPlus.org).
Collections
Institution/Community
Institut za medicinska istraživanjaTY - JOUR AU - Knez, Marija AU - Boy, Erick PY - 2023 UR - http://rimi.imi.bg.ac.rs/handle/123456789/1290 AB - The role of Zn in human health was discovered 60 years ago, and despite remarkable research efforts, a sufficiently sensitive and specific biomarker of Zn status is still lacking. Plasma/serum Zn, currently the best available and most accepted population Zn status indicator, responds well to severe Zn deficiency, yet, mild to moderate Zn deficiency states usually remain unrecognized. Identifying early-stage Zn deficiency requires additional robust markers of Zn status. This paper discusses the sensitivity, specificity, and responsiveness of plasma Zn concentrations to Zn interventions. It describes the biochemical and dietary basis for the causal association between Zn and fatty acid desaturases activity, FADS1 and FADS2, based on data collected through studies performed in animals and/or humans. The influence of potential confounders and covariates on the observed relationships is considered. Additional potential Zn biomarkers are discussed and suggestions for further research in this area are provided. PB - Frontiers Media S.A. T2 - Frontiers in Nutrition T1 - Existing knowledge on Zn status biomarkers (1963–2021) with a particular focus on FADS1 and FADS2 diagnostic performance and recommendations for further research SP - 1057156 VL - 9 DO - 10.3389/fnut.2022.1057156 ER -
@article{ author = "Knez, Marija and Boy, Erick", year = "2023", abstract = "The role of Zn in human health was discovered 60 years ago, and despite remarkable research efforts, a sufficiently sensitive and specific biomarker of Zn status is still lacking. Plasma/serum Zn, currently the best available and most accepted population Zn status indicator, responds well to severe Zn deficiency, yet, mild to moderate Zn deficiency states usually remain unrecognized. Identifying early-stage Zn deficiency requires additional robust markers of Zn status. This paper discusses the sensitivity, specificity, and responsiveness of plasma Zn concentrations to Zn interventions. It describes the biochemical and dietary basis for the causal association between Zn and fatty acid desaturases activity, FADS1 and FADS2, based on data collected through studies performed in animals and/or humans. The influence of potential confounders and covariates on the observed relationships is considered. Additional potential Zn biomarkers are discussed and suggestions for further research in this area are provided.", publisher = "Frontiers Media S.A.", journal = "Frontiers in Nutrition", title = "Existing knowledge on Zn status biomarkers (1963–2021) with a particular focus on FADS1 and FADS2 diagnostic performance and recommendations for further research", pages = "1057156", volume = "9", doi = "10.3389/fnut.2022.1057156" }
Knez, M.,& Boy, E.. (2023). Existing knowledge on Zn status biomarkers (1963–2021) with a particular focus on FADS1 and FADS2 diagnostic performance and recommendations for further research. in Frontiers in Nutrition Frontiers Media S.A.., 9, 1057156. https://doi.org/10.3389/fnut.2022.1057156
Knez M, Boy E. Existing knowledge on Zn status biomarkers (1963–2021) with a particular focus on FADS1 and FADS2 diagnostic performance and recommendations for further research. in Frontiers in Nutrition. 2023;9:1057156. doi:10.3389/fnut.2022.1057156 .
Knez, Marija, Boy, Erick, "Existing knowledge on Zn status biomarkers (1963–2021) with a particular focus on FADS1 and FADS2 diagnostic performance and recommendations for further research" in Frontiers in Nutrition, 9 (2023):1057156, https://doi.org/10.3389/fnut.2022.1057156 . .